fosphenytoin: Clinical Trials

11 trials of fosphenytoin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 4 terminated. 3 Phase 3, 3 Phase 4, 2 Not applicable, 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3
Phase 43Completed 2, Terminated 1
Not applicable2Terminated 2
Phase 22Completed 1, Terminated 1
Phase 11Terminated 1

Follow fosphenytoin: new trials by email Literature Review of fosphenytoin trials Research Report on fosphenytoin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Antiseizure Medication in Seizure Networks at Early Acute Brain Injury
Phenobarbital Sodium Injection, Levetiracetam, Lacosamide Injectable Product - Brain Injuries, Acute, Brain Injuries, Traumatic
Phase 4TerminatedUniversity of North Carolina, Chapel Hill52023-11-202025-11-14
The Efficacy and Safety of Levetiracetam Versus Fosphenytoin in Convulsive Status Epilepticus
Levetiracetam Injection, Fosphenytoin Injection - Status Epilepticus
Phase 4CompletedDhaka Medical College622023-05-152026-10-07
Phenytoin as Treatment for Acute Exacerbations of Trigeminal Neuralgia - a Prospective Systematic Study of 20 Patients
Fosphenytoin - Trigeminal Neuralgia
CompletedDanish Headache Center152018-11-012022-03-24
Established Status Epilepticus Treatment Trial
Fosphenytoin, Levetiracetam, Valproic acid - Benzodiazepine Refractory Status Epilepticus
Phase 3CompletedUniversity of Virginia4782015-10-012021-06-14
Comparison Between Lorazepam, Clonazepam and Clonazepam + Fosphenytoin for the Treatment of Out-of-hospital Generalized Status Epilepticus
Clonazepam, Fosphenytoin, Placebo - Status Epilepticus, Epilepsy
Phase 3CompletedAssistance Publique - Hôpitaux de Paris4342013-06-262018-10-11
Intravenous Lacosamide Compared With Fosphenytoin in the Treatment of Patients With Frequent Nonconvulsive Seizures
fPHT, LCM - Nonconvulsive Seizures
Phase 2CompletedAatif Husain742012-05-012018-06-11
A Pilot Study of NSICU Assessment of Seizure Prophylaxis With Lacosamide
lacosamide, Fosphenytoin - Traumatic Brain Injury
Not applicableTerminatedUniversity of Alabama at Birmingham112010-05-012014-04-28
The Study of NPC-06 - Investigation of Safety, Efficacy and Pharmacokinetics of Fosphenytoin
fosphenytoin - Epilepsy
Phase 3CompletedNobelpharma402009-05-012010-05-24
Antiepileptic Drugs and Vascular Risk Markers
phenytoin, valproate, levetiracetam - Subarachnoid Hemorrhage
Not applicableTerminatedThomas Jefferson University522009-04-012017-12-18
Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders
Alemtuzumab, Total Body Irradiation, Melphalan - Leukemia, Lymphoma
Phase 1 / Phase 2TerminatedColumbia University12007-09-062019-03-27
IV Keppra in the Emergency Department for Prevention of Early Recurrent Seizures
Keppra, Fosphenytoin, Dilantin - Tonic-clonic Seizure
Phase 4CompletedEmory University1582007-07-012013-12-12

Conditions studied

Seizures (4)  ·  Status Epilepticus (3)  ·  Brain Injuries, Traumatic (2)  ·  Epilepsy (2)  ·  Acute Pain (1)  ·  Anemia (1)  ·  Brain Injuries (1)  ·  Brain Ischemia (1)  ·  Coma (1)  ·  Emergencies (1)  ·  Epilepsy, Tonic-Clonic (1)  ·  Heart Arrest (1)  ·  Hypoxia, Brain (1)  ·  Hypoxia-Ischemia, Brain (1)  ·  Immunologic Deficiency Syndromes (1)

Sponsors

Aatif Husain (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Columbia University (1)  ·  Danish Headache Center (1)  ·  Dhaka Medical College (1)  ·  Emory University (1)  ·  Nobelpharma (1)  ·  Thomas Jefferson University (1)  ·  University of Alabama at Birmingham (1)  ·  University of North Carolina, Chapel Hill (1)  ·  University of Virginia (1)

Countries

United States (6)  ·  Bangladesh (1)  ·  Denmark (1)  ·  France (1)  ·  Japan (1)

Top investigators

Aatif Husain, MD (1)  ·  Debra Houry, MD (1)  ·  Dr Md Amirul Islam, MBBS (1)  ·  Dr Reaz Mahmud, MD (1)  ·  Eiji Nakagawa, M.D. (1)  ·  Emilio G. Cediel, MD (1)  ·  Jaideep Kapur, MBBS, PhD (1)  ·  James Chamberlain, MD (1)  ·  Jerzy P Szaflarski, M.D., PhD (1)  ·  Jordan Elm, PhD (1)  ·  Prakash Satwani, MD (1)  ·  Robert Silbergleit, MD (1)

Results publications

PMID 23953988, PMID 31161706, PMID 31774955, PMID 32203691, PMID 32446674, PMID 33336359, PMID 33567109, PMID 33742783, PMID 34032604, PMID 35469443, PMID 35718575

NIH funding

K23NS058669 (1), U01NS088034 (1)